Comparison of Diazepam and Phenytoin in Patients of Less Than One Year with Status Epilepticus

Muhammad Saqib Zaman; Karishma Siraj; Mansoor Ahmad; Muhammad Waqar; Abdul Hameed

doi:10.70749/ijbr.v3i4.1164

Authors

Muhammad Saqib Zaman Department of Pediatric Medicine, Lady Reading Hospital, Peshawar, Pakistan.
Karishma Siraj Department of Pediatric Medicine, Lady Reading Hospital, Peshawar, Pakistan.
Mansoor Ahmad Department of Pediatric Medicine, Lady Reading Hospital, Peshawar, Pakistan.
Muhammad Waqar Department of Pediatric Medicine, Lady Reading Hospital, Peshawar, Pakistan.
Abdul Hameed Department of Pediatric Medicine, Lady Reading Hospital, Peshawar, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i4.1164

Keywords:

Status epilepticus, Diazepam, Phenytoin, Pediatric seizures, Anticonvulsants, Efficacy

Abstract

Background: Status epilepticus in children is a critical emergency and requires prompt treatment to avoid long term consequences. Anticonvulsants such as phenytoin and diazepam are used commonly to treat this condition. But while the two drugs are very different, there’s still no consensus on which is more effective in young children. Objective: To compare the efficacy of diazepam and phenytoin in children less than one year of age with status epilepticus. Study Design: Randomized controlled trial. Duration and Place of Study: The study was conducted from February 2024 to August 2024 at the Department of Pediatric Medicine, LRH Peshawar. Methodology: Sixty children, 1–12 months old with status epilepticus were randomly assigned into two groups; Group A (phenytoin), n = 30 and Group B (diazepam), n = 30. Diazepam was given at 0.2 mg/kg, and phenytoin at 15–20 mg/kg. Cessation of seizures within 10 minutes and no recurrence within 12 hours was measured as efficacy. And they analyzed data using IBM SPSS version 26 and set statistical significance at p. value. Results: Group B (diazepam) showed a significantly higher seizure cessation rate (83.3%) compared to Group A (46.7%) (p=0.006). Stratified analyses indicated that diazepam was particularly more effective in female patients (p=0.011) and those with a lower body weight (≤8 kg) (p=0.015). Additionally, for complaints lasting longer than 24 hours, diazepam had a markedly higher efficacy (88.9% vs. 5.9%, p=0.000). Conclusion: Diazepam is more effective than phenytoin for managing status epilepticus in children under one year of age. The results support the use of diazepam as the first-line treatment due to its rapid onset of action and superior efficacy, particularly in patients with lower body weight and longer duration of seizures.

Downloads

Download data is not yet available.

References

Blair RE, Hawkins E, Pinchbeck LR, DeLorenzo RJ, Deshpande LS. Chronic epilepsy and mossy fiber sprouting following organophosphate-induced status epilepticus in rats. J Pharmacol Exp Ther. 2024 Jan 17;388(2):325-332. https://doi.org/10.1124/jpet.123.001739.

Spoto G, Saia MC, Amore G, Gitto E, Loddo G, Mainieri G, et al. Neonatal seizures: an overview of genetic causes and treatment options. Brain Sci. 2021 Sep 29;11(10):1295. https://doi.org/10.3390/brainsci11101295.

Bartolini E, Ferrari AR, Fiori S, Della Vecchia S. Glycaemic imbalances in seizures and epilepsy of paediatric age: a literature review. J Clin Med. 2023 Mar 29;12(7):2580. https://doi.org/10.3390/jcm12072580.

Abend NS, Loddenkemper T. Pediatric status epilepticus management. Curr Opin Pediatr. 2014 Dec;26(6):668-74. https://doi.org/10.1097/MOP.0000000000000154.

McKenzie KC, Hahn CD, Friedman JN. Emergency management of the paediatric patient with convulsive status epilepticus. Paediatr Child Health. 2021 Jan 21;26(1):50-66. https://doi.org/10.1093/pch/pxaa127.

Kienitz R, Kay L, Beuchat I, Gelhard S, von Brauchitsch S, Mann C, et al. Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability. CNS Drugs. 2022 Sep;36(9):951-975. https://doi.org/10.1007/s40263-022-00940-2.

Nakamura K, Marushima A, Takahashi Y, Mochizuki M, Kimura A, Fukuda Y, et al. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial. J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):42-48. https://doi.org/10.1136/jnnp-2022-329485.

Aulická Š. Current management of generalized convulsive status epilepticus in children. Children (Basel). 2022 Oct 20;9(10):1586. https://doi.org/10.3390/children9101586.

Sheehan T, Amengual-Gual M, Vasquez A, Abend NS, Anderson A, Appavu B, et al. Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus. Epilepsia. 2021 Nov;62(11):2766-2777. https://doi.org/10.1111/epi.17043.

Fiani B, Andraos C, Mabry I, Siddiqi J. A comparison of seizure prophylaxis: phenytoin versus levetiracetam. Cureus. 2021 May 11;13(5):e14956. https://doi.org/10.7759/cureus.14956.

Löscher W, Klein P. The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS Drugs. 2021 Sep;35(9):935-963. https://doi.org/10.1007/s40263-021-00827-8.

Nair SC, Vinayan KP, Mangalathillam S. Nose to brain delivery of phenytoin sodium loaded nano lipid carriers: formulation, drug release, permeation and in vivo pharmacokinetic studies. Pharmaceutics. 2021 Oct 8;13(10):1640. https://doi.org/10.3390/pharmaceutics13101640.

Purwien L, Schubert-Bast S, Kieslich M, Ronellenfitsch MW, Merker M, Czabanka M, et al. Trends and differences in status epilepticus treatment of children and adults over 10 years: a comparative study of medical records (2012-2021) from a university hospital in Germany. CNS Drugs. 2023 Nov;37(11):993-1008. https://doi.org/10.1007/s40263-023-01049-w.

Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125-34. https://doi.org/10.3410/f.735591153.793567262

Momen AA, Azizi Malamiri R, Nikkhah A, Jafari M, Fayezi A, Riahi K, et al. Efficacy and safety of intramuscular midazolam versus rectal diazepam in controlling status epilepticus in children. Eur J Paediatr Neurol. 2015;19(2):149-54. https://doi.org/10.1016/j.ejpn.2014.11.007

Momen AA, et al. Diazepam efficacy in treating children with status epilepticus. Pediatr Neurol. https://doi.org/10.1016/j.pediatrneurol.2019.10.001.

Lyttle MD, et al. Phenytoin efficacy in children with status epilepticus. Arch Dis Child. https://doi.org/ 10.1136/archdischild-2019-318081.

Messahel S, Bracken L, Appleton R. Optimal management of status epilepticus in children in the emergency setting: a review of recent advances. Open Access Emerg Med. 2022;14:491-506. https://doi.org/10.1016/j.pediatrneurol.2021.10.001.

Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol. 2012;259:645-648. https://doi.org/10.1007/s00415-011-6227-2.

Smith DM, McGinnis EL, Walleigh DJ, Abend NS. Management of status epilepticus in children. J Clin Med. 2016;5(4):47. https://doi.org/10.3390/jcm5040047.